当前位置: 首页 >> 检索结果
共有 468 条符合本次的查询结果, 用时 1.8863117 秒

1. Gamma-glutamyltransferase and the survival of hepatocellular carcinoma patients after transarterial chemoembolization: a meta‑analysis and systematic review.

作者: Zixin Huang.;Manli Zhou.;Sisi Feng.;Xiaomin Xiao.;Baiyun Zhong.
来源: BMC Gastroenterol. 2025年25卷1期802页
Plentiful studies have reported that preoperative gamma-glutamyltransferase (GGT) had a strong relationship with the prognosis of hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization (TACE). Nevertheless, due to the small sample size and contradictory conclusions, the predictive function remains indefinite. To investigate the relationship between pretreatment GGT value and clinical outcomes in HCC patients undergoing TACE, a meta-analysis including 10 articles was constructed.

2. The effect of intravenous anesthesia on postoperative cognitive function in patients undergoing painless gastroscopy: a meta-analysis.

作者: Zhen Jia.;Yubai Leng.;Yetie Fan.;Wanwan Ji.;Bin Zhou.;Zhiming Tan.
来源: BMC Gastroenterol. 2025年25卷1期803页
With the development of comfortable medical care, the application of intravenous anesthesia in painless gastroscopy is becoming increasingly widespread. However, anesthetic drugs may have adverse effects on postoperative cognitive function, and the risk of postoperative cognitive dysfunction (POCD) is particularly worthy of attention in the elderly population. Our aim is to evaluate the effect of intravenous anesthesia on postoperative cognitive function (POCF) in patients undergoing painless gastroscopy, with a focus on identifying potential risks of POCD and guiding clinical anesthesia practices.

3. Risk factors for incomplete excision of colorectal polyps: a systematic review and meta-analysis.

作者: Zhongxin Sun.;Tengfei Cao.;Wen Wei.;Jiao Li.;Jing Shan.;Weidong Xi.;Xiaobin Sun.
来源: BMC Gastroenterol. 2025年25卷1期796页
The object of this study was to explore the risk factors for incomplete excision of colorectal polyps (CP) through a systematic review and meta-analysis.

4. Effects of enhanced recovery after surgery nursing on patients undergoing laparoscopic colectomy: a systematic review and meta-analysis.

作者: Dan Zhang.;Miaoxiu Zhong.;Liujia Jin.;Lingling Chen.
来源: BMC Gastroenterol. 2025年25卷1期788页
This study aimed to systematically evaluate the effects of Enhanced Recovery After Surgery (ERAS) nursing protocols on patients undergoing laparoscopic colectomy.

5. Efficacy of N-Acetylcysteine in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis.

作者: Ahmad Hormati.;Asma Mousavi.;Shayan Shojaei.;Atie Moghtadaei.;Sanaz Bordbar.;Hediyeh Alemi.;Amir Kasaeian.;Sadaf Sepanlou.
来源: BMC Gastroenterol. 2025年25卷1期783页
Endoscopic retrograde cholangiopancreatography (ERCP) is a widely utilized procedure for diagnosing and treating biliary and pancreatic disorders. However, it carries a risk of post-ERCP pancreatitis (PEP). N-Acetylcysteine (NAC) has been proposed as a potential prophylactic agent due to its antioxidant properties, yet its efficacy remains debated. This systematic review and meta-analysis aimed to evaluate the effectiveness of NAC in preventing PEP in patients undergoing ERCP.

6. Risk prediction models for lymph node metastasis in early gastric cancer patients: a systematic review and meta-analysis.

作者: Meng Duan.;Min Li.;Lei He.;Shiming Dai.;Lang Zhou.;Zhiqun Liu.;Jie Yang.;Lingyuan Chen.;Xiang Liu.;Zhaoshu Wu.
来源: BMC Gastroenterol. 2025年25卷1期776页
The number of risk prediction models for lymph node metastasis in early gastric cancer is increasing, but the quality and applicability of these models in clinical practice and future research remain unknown.

7. Efficacy of TDF, TAF, TMF, and TDF-to-TAF switch in chronic hepatitis B: a network meta-analysis.

作者: Shuqi Yang.;Yijie Lin.;Huatang Zhang.;Yanlan Liang.;Wenjin Yuan.;Xing Wang.;Wenwu Lin.;Wencong Hong.;Zhijun Su.;Dawu Zeng.;Xueping Yu.
来源: BMC Gastroenterol. 2025年25卷1期760页
We compared the efficacy of four treatment strategies for chronic hepatitis B (CHB): tenofovir disoproxil fumarate (TDF), tenofovir alafenamide (TAF), tenofovir amibufenamide (TMF), and TDF-to-TAF switch strategies strategy. We conducted a network meta-analysis to provide evidence-based clinical guidance.

8. Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn's Disease: 2025 AGA Evidence Synthesis.

作者: Siddharth Singh.;M Hassan Murad.;Yuhong Yuan.;Ashwin N Ananthakrishnan.;Benjamin Click.;Gaurav Syal.;John P Haydek.;Manasi Agrawal.;Michael D Kappelman.;James D Lewis.;Frank I Scott.
来源: Gastroenterology. 2025年169卷7期1516-1536页
We performed an updated systematic review and network meta-analysis to inform the 2025 American Gastroenterological Association Clinical Guidelines on the management of moderate-to-severe Crohn's disease (CD).

9. Efficacy of hydration combined with rectal non-steroidal anti-inflammatory drugs (NSAIDs) versus NSAIDs alone for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis of randomized controlled trials.

作者: Huimin Li.;Changfeng Miao.;Wei Fang.;Yuan Deng.;Xiong Li.;Ting Du.;Hongwei Tian.
来源: BMC Gastroenterol. 2025年25卷1期738页
The most prevalent complication of endoscopic retrograde cholangiopancreatography (ERCP) is post-ERCP acute pancreatitis (PEP). Both hydration and rectal non-steroidal anti-inflammatory drugs (NSAIDs) can effectively prevent PEP; however, there is currently no consensus on whether combination therapy is more effective than either intervention alone.

10. Population stratified differences between ATG16L1 rs2241880 polymorphism with Crohn's disease risk: a systematic review and meta-analysis.

作者: Yiyuan Gao.;Yuan Zhang.;Peidu Jiang.
来源: BMC Gastroenterol. 2025年25卷1期735页
ATG16L1 rs2241880 (T300A), a single-nucleotide variant, plays a controversial role in the development of Crohn's disease (CD).

11. Early oral feeding after laparoscopic total gastrectomy in gastric cancer patients: a meta-analysis of randomized controlled trials and cohort studies.

作者: Leila Mohajeri.;Reza Daghayeghi.;Navid Rostami.;Yasamin Moeinipour.;Reza Hossein Zadeh.;Raoul Hossein Zadeh.;Reza Shah Hosseini.;Mohsen Jabbari.;Komeil Aghazadeh Habashi.;Niloofar Deravi.
来源: BMC Gastroenterol. 2025年25卷1期709页
Gastric cancer remains a leading cause of cancer-related morbidity and mortality worldwide, with surgery being central to treatment. However, postoperative malnutrition is common and significantly impairs recovery. Early oral feeding (EOF) has been proposed as a strategy to promote gastrointestinal recovery and reduce complications, but its clinical effectiveness following gastrectomy remains uncertain.

12. Global prevalence of metabolic dysfunction-associated fatty liver disease in children and adolescents with overweight and obesity: a systematic review and meta-analysis.

作者: Shuangzhen Jia.;Xiaolin Ye.;Tianwei Wu.;Zhaoxia Wang.;Jie Wu.
来源: BMC Gastroenterol. 2025年25卷1期691页
The prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) among children and adolescents with overweight and/or obesity is rising globally, reflecting increasing obesity rates and metabolic syndrome. This study aims to provide a comprehensive global estimate of MAFLD prevalence in this population.

13. Glutamine prevents diarrhea in colorectal cancer patients undergoing chemotherapy or chemoradiotherapy: a meta-analysis.

作者: Lijuan Chen.;Duo Wang.;Chang Meng.;Hongshuo Sun.;Ruolin Li.;Guobin Miao.;Peng Liu.
来源: BMC Gastroenterol. 2025年25卷1期697页
To assess the efficacy of glutamine in preventing diarrhea associated with chemotherapy or chemoradiotherapy in colorectal cancer.

14. The impact of fecal microbiota transplantation on refractory ulcerative colitis: A systematic review and Meta-Analysis of randomised controlled trials.

作者: Chidi Arthur Igbo.;Chimezirim Ezeano.;Olanrewaju Adeniran.;Maher Taha.;Albert Alexis Annan.;Valentine C Nriagu.;Sarpong Boateng.;Madu Chimezie Williams.;Chike Onyali.
来源: BMC Gastroenterol. 2025年25卷1期654页
Refractory ulcerative colitis (UC), characterized by persistent disease activity despite optimized medical therapy, poses a significant therapeutic challenge. Fecal microbiota transplantation (FMT) has shown promise in inducing remission in active ulcerative colitis (UC) by restoring gut microbial balance; however, its efficacy in refractory cases remains unclear. This systematic review and meta-analysis aimed to evaluate the effectiveness and safety of FMT in achieving clinical and endoscopic remission in patients with refractory UC, based on evidence from randomized controlled trials (RCTs).

15. Effect of single-day versus multi-day low-residue diet on colonoscopy bowel preparation: a systematic review and meta -analysis.

作者: Jing Du.;Xueqian He.;Peng Li.
来源: BMC Gastroenterol. 2025年25卷1期648页
To compare the effects of single-day and multi-day low-residue diets on bowel preparation quality and patient tolerance of colonoscopy.

16. Ulinastatin for the treatment of severe acute pancreatitis: a systematic review and meta-analysis.

作者: Sanjay Bandyopadhyay.;Shambo Samrat Samajdar.;Saibal Das.
来源: BMC Gastroenterol. 2025年25卷1期629页
Severe acute pancreatitis (SAP) lacks a definitive treatment option. Although ulinastatin has demonstrated anti-inflammatory and organ-preserving properties, its role in SAP remains unclear due to divergent findings. Hence, we evaluated the efficacy and role of ulinastatin in patients with SAP.

17. Effect of magnetically guided capsule endoscopy on gastrointestinal transit time and diagnostic yield: a systematic review and meta-analysis.

作者: Amar Lal.;Ragini Gopagoni.;Fnu Manisha.;Rumaisa Siddiqui.;Asif Hussain.;Fnu Riya.;Nayyar Iqbal Tiwana.;Rahul Rai.;Rabia Kamran.;Sajida Moiz Hussain Qamari.;Muhammad Burhan.;Mohammad Jawwad.;Hira Riaz.
来源: BMC Gastroenterol. 2025年25卷1期624页
Capsule endoscopy (CE) is a primary tool for small bowel visualization, but its diagnostic yield can be limited by prolonged transit times and finite battery life. Various interventions, including prokinetics, purgatives, and magnetic steering, are used to optimize CE performance. This systematic review and meta-analysis compare the effectiveness of these strategies in improving transit times and completion rates.

18. Association between GLP-1 receptor agonists as a class and colorectal cancer risk: a meta-analysis of retrospective cohort studies.

作者: Ying Zhong.;Tingting Wu.;Najeeb Ullah Khan.
来源: BMC Gastroenterol. 2025年25卷1期614页
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are extensively used in the management of type 2 diabetes mellitus (T2DM) and obesity. While these medications offer glycemic control and cardiovascular benefits, the risks have increased because of their potential impact on cancer risk, particularly colorectal cancer (CRC). This meta-analysis aimed to evaluate the association between GLP-1 RAs and CRC risk in patients receiving GLP-1 RAs.

19. Mycophenolate mofetil versus azathioprine as a first-line treatment for autoimmune hepatitis: a comparative systematic review and meta-analysis.

作者: Amani M Ali.;Mohamed E Abdelrahim.;Aya M AbdelMagid.
来源: BMC Gastroenterol. 2025年25卷1期613页
Autoimmune hepatitis (AIH) is a chronic progressive inflammatory liver disease of immune-mediated origin, which causes long-term liver inflammation and damage. Traditionally, treatment includes azathioprine (AZA) combined with steroids, but recent studies have highlighted mycophenolate mofetil (MMF) as a potential alternative, particularly for patients who do not respond well to AZA.

20. The prognostic value of indoleamine 2,3-dioxygenase in colorectal cancer: a systematic review and meta-analysis.

作者: Tingting Yuan.;Guiqing Jia.;Wei Cao.;Haixia Chen.;Jing Zhang.;Min Liu.;Wenwen Gan.;Yanli Zeng.
来源: BMC Gastroenterol. 2025年25卷1期603页
This study aims to evaluate the association between IDO index and the prognosis of colorectal cancer (CRC). We searched databases such as PubMed, to collect relevant English studies on the association between IDO level and the prognosis of CRC published before October 10, 2024. This meta-analysis included 11 studies involving 2068 patients. The results showed that IDO levels were not significantly correlated with OS in CRC patients (HR0.85, 95%CI 0.54-1.33, P = 0.488), but elevated IDO was associated with reduced disease-free survival (DFS) in CRC patients (HR 0.61, 95%CI 0.38-0.99, P = 0.044).Elevated IDO was significantly associated with the incidence of liver metastasis (HR 4.66, 95%CI 1.72-12.64, P = 0.003) and lymphatic infiltration (HR 2.75, 95%CI 1.52-4.97, P < 0.001) in CRC patients. In conclusion, high expression of IDO is significantly associated with DFS, liver metastasis and lymphatic infiltration in CRC patients, and may serve as a biomarker and therapeutic target for DFS, liver metastasis, and lymphatic metastasis in CRC.
共有 468 条符合本次的查询结果, 用时 1.8863117 秒